Pharma & Healthcare
Global IL-17 Targeting Biological Drugs Market Research Report 2026
- May 01, 26
- ID: 748366
- Pages: 111
- Figures: 114
- Views: 6
This report delivers a comprehensive overview of the global IL-17 Targeting Biological Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding IL-17 Targeting Biological Drugs. The IL-17 Targeting Biological Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global IL-17 Targeting Biological Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist IL-17 Targeting Biological Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Chongqing Genrix Biopharmaceutical
Jiangsu Hengrui Medicine
Novartis
UCB
Eli Lilly and Co.
Akesobio
AstraZeneca
DICE Therapeutics
Segment by Type
Oral
Injection
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for IL-17 Targeting Biological Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines IL-17 Targeting Biological Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global IL-17 Targeting Biological Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist IL-17 Targeting Biological Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Chongqing Genrix Biopharmaceutical
Jiangsu Hengrui Medicine
Novartis
UCB
Eli Lilly and Co.
Akesobio
AstraZeneca
DICE Therapeutics
Segment by Type
Oral
Injection
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for IL-17 Targeting Biological Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines IL-17 Targeting Biological Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 IL-17 Targeting Biological Drugs Market Overview
1.1 Product Definition
1.2 IL-17 Targeting Biological Drugs by Type
1.2.1 Global IL-17 Targeting Biological Drugs Market Value by Type: 2025 vs 2032
1.2.2 Oral
1.2.3 Injection
1.3 IL-17 Targeting Biological Drugs by Application
1.3.1 Global IL-17 Targeting Biological Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global IL-17 Targeting Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global IL-17 Targeting Biological Drugs Revenue 2021–2032
1.4.2 Global IL-17 Targeting Biological Drugs Sales 2021–2032
1.4.3 Global IL-17 Targeting Biological Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 IL-17 Targeting Biological Drugs Market Competition by Manufacturers
2.1 Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global IL-17 Targeting Biological Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Types and Applications
2.7 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Entry into the Industry
2.8 Global IL-17 Targeting Biological Drugs Market Competitive Situation and Trends
2.8.1 Global IL-17 Targeting Biological Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global IL-17 Targeting Biological Drugs Players Market Share by Revenue
2.8.3 Global IL-17 Targeting Biological Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-17 Targeting Biological Drugs Market Scenario by Region
3.1 Global IL-17 Targeting Biological Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2021–2032
3.2.1 Global IL-17 Targeting Biological Drugs Sales by Region: 2021–2026
3.2.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2027–2032
3.3 Global IL-17 Targeting Biological Drugs Revenue by Region: 2021–2032
3.3.1 Global IL-17 Targeting Biological Drugs Revenue by Region: 2021–2026
3.3.2 Global IL-17 Targeting Biological Drugs Revenue by Region: 2027–2032
3.4 North America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.4.1 North America IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.4.3 North America IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.5.1 Europe IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.5.3 Europe IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-17 Targeting Biological Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific IL-17 Targeting Biological Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.7.1 Latin America IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.7.3 Latin America IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-17 Targeting Biological Drugs Sales by Type (2021–2032)
4.1.1 Global IL-17 Targeting Biological Drugs Sales by Type (2021–2026)
4.1.2 Global IL-17 Targeting Biological Drugs Sales by Type (2027–2032)
4.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021–2032)
4.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2021–2032)
4.2.1 Global IL-17 Targeting Biological Drugs Revenue by Type (2021–2026)
4.2.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2027–2032)
4.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021–2032)
4.3 Global IL-17 Targeting Biological Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global IL-17 Targeting Biological Drugs Sales by Application (2021–2032)
5.1.1 Global IL-17 Targeting Biological Drugs Sales by Application (2021–2026)
5.1.2 Global IL-17 Targeting Biological Drugs Sales by Application (2027–2032)
5.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021–2032)
5.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2021–2032)
5.2.1 Global IL-17 Targeting Biological Drugs Revenue by Application (2021–2026)
5.2.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2027–2032)
5.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021–2032)
5.3 Global IL-17 Targeting Biological Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chongqing Genrix Biopharmaceutical
6.1.1 Chongqing Genrix Biopharmaceutical Company Information
6.1.2 Chongqing Genrix Biopharmaceutical Description and Business Overview
6.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio
6.1.5 Chongqing Genrix Biopharmaceutical Recent Developments/Updates
6.2 Jiangsu Hengrui Medicine
6.2.1 Jiangsu Hengrui Medicine Company Information
6.2.2 Jiangsu Hengrui Medicine Description and Business Overview
6.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio
6.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novartis IL-17 Targeting Biological Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB
6.4.1 UCB Company Information
6.4.2 UCB Description and Business Overview
6.4.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 UCB IL-17 Targeting Biological Drugs Product Portfolio
6.4.5 UCB Recent Developments/Updates
6.5 Eli Lilly and Co.
6.5.1 Eli Lilly and Co. Company Information
6.5.2 Eli Lilly and Co. Description and Business Overview
6.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio
6.5.5 Eli Lilly and Co. Recent Developments/Updates
6.6 Akesobio
6.6.1 Akesobio Company Information
6.6.2 Akesobio Description and Business Overview
6.6.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Akesobio IL-17 Targeting Biological Drugs Product Portfolio
6.6.5 Akesobio Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 DICE Therapeutics
6.8.1 DICE Therapeutics Company Information
6.8.2 DICE Therapeutics Description and Business Overview
6.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio
6.8.5 DICE Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-17 Targeting Biological Drugs Industry Chain Analysis
7.2 IL-17 Targeting Biological Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-17 Targeting Biological Drugs Production Mode & Process Analysis
7.4 IL-17 Targeting Biological Drugs Sales and Marketing
7.4.1 IL-17 Targeting Biological Drugs Sales Channels
7.4.2 IL-17 Targeting Biological Drugs Distributors
7.5 IL-17 Targeting Biological Drugs Customer Analysis
8 IL-17 Targeting Biological Drugs Market Dynamics
8.1 IL-17 Targeting Biological Drugs Industry Trends
8.2 IL-17 Targeting Biological Drugs Market Drivers
8.3 IL-17 Targeting Biological Drugs Market Challenges
8.4 IL-17 Targeting Biological Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 IL-17 Targeting Biological Drugs by Type
1.2.1 Global IL-17 Targeting Biological Drugs Market Value by Type: 2025 vs 2032
1.2.2 Oral
1.2.3 Injection
1.3 IL-17 Targeting Biological Drugs by Application
1.3.1 Global IL-17 Targeting Biological Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global IL-17 Targeting Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global IL-17 Targeting Biological Drugs Revenue 2021–2032
1.4.2 Global IL-17 Targeting Biological Drugs Sales 2021–2032
1.4.3 Global IL-17 Targeting Biological Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 IL-17 Targeting Biological Drugs Market Competition by Manufacturers
2.1 Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global IL-17 Targeting Biological Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Types and Applications
2.7 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Entry into the Industry
2.8 Global IL-17 Targeting Biological Drugs Market Competitive Situation and Trends
2.8.1 Global IL-17 Targeting Biological Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global IL-17 Targeting Biological Drugs Players Market Share by Revenue
2.8.3 Global IL-17 Targeting Biological Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-17 Targeting Biological Drugs Market Scenario by Region
3.1 Global IL-17 Targeting Biological Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2021–2032
3.2.1 Global IL-17 Targeting Biological Drugs Sales by Region: 2021–2026
3.2.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2027–2032
3.3 Global IL-17 Targeting Biological Drugs Revenue by Region: 2021–2032
3.3.1 Global IL-17 Targeting Biological Drugs Revenue by Region: 2021–2026
3.3.2 Global IL-17 Targeting Biological Drugs Revenue by Region: 2027–2032
3.4 North America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.4.1 North America IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.4.3 North America IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.5.1 Europe IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.5.3 Europe IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-17 Targeting Biological Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific IL-17 Targeting Biological Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.7.1 Latin America IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.7.3 Latin America IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-17 Targeting Biological Drugs Sales by Type (2021–2032)
4.1.1 Global IL-17 Targeting Biological Drugs Sales by Type (2021–2026)
4.1.2 Global IL-17 Targeting Biological Drugs Sales by Type (2027–2032)
4.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021–2032)
4.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2021–2032)
4.2.1 Global IL-17 Targeting Biological Drugs Revenue by Type (2021–2026)
4.2.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2027–2032)
4.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021–2032)
4.3 Global IL-17 Targeting Biological Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global IL-17 Targeting Biological Drugs Sales by Application (2021–2032)
5.1.1 Global IL-17 Targeting Biological Drugs Sales by Application (2021–2026)
5.1.2 Global IL-17 Targeting Biological Drugs Sales by Application (2027–2032)
5.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021–2032)
5.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2021–2032)
5.2.1 Global IL-17 Targeting Biological Drugs Revenue by Application (2021–2026)
5.2.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2027–2032)
5.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021–2032)
5.3 Global IL-17 Targeting Biological Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chongqing Genrix Biopharmaceutical
6.1.1 Chongqing Genrix Biopharmaceutical Company Information
6.1.2 Chongqing Genrix Biopharmaceutical Description and Business Overview
6.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio
6.1.5 Chongqing Genrix Biopharmaceutical Recent Developments/Updates
6.2 Jiangsu Hengrui Medicine
6.2.1 Jiangsu Hengrui Medicine Company Information
6.2.2 Jiangsu Hengrui Medicine Description and Business Overview
6.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio
6.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novartis IL-17 Targeting Biological Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB
6.4.1 UCB Company Information
6.4.2 UCB Description and Business Overview
6.4.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 UCB IL-17 Targeting Biological Drugs Product Portfolio
6.4.5 UCB Recent Developments/Updates
6.5 Eli Lilly and Co.
6.5.1 Eli Lilly and Co. Company Information
6.5.2 Eli Lilly and Co. Description and Business Overview
6.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio
6.5.5 Eli Lilly and Co. Recent Developments/Updates
6.6 Akesobio
6.6.1 Akesobio Company Information
6.6.2 Akesobio Description and Business Overview
6.6.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Akesobio IL-17 Targeting Biological Drugs Product Portfolio
6.6.5 Akesobio Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 DICE Therapeutics
6.8.1 DICE Therapeutics Company Information
6.8.2 DICE Therapeutics Description and Business Overview
6.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio
6.8.5 DICE Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-17 Targeting Biological Drugs Industry Chain Analysis
7.2 IL-17 Targeting Biological Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-17 Targeting Biological Drugs Production Mode & Process Analysis
7.4 IL-17 Targeting Biological Drugs Sales and Marketing
7.4.1 IL-17 Targeting Biological Drugs Sales Channels
7.4.2 IL-17 Targeting Biological Drugs Distributors
7.5 IL-17 Targeting Biological Drugs Customer Analysis
8 IL-17 Targeting Biological Drugs Market Dynamics
8.1 IL-17 Targeting Biological Drugs Industry Trends
8.2 IL-17 Targeting Biological Drugs Market Drivers
8.3 IL-17 Targeting Biological Drugs Market Challenges
8.4 IL-17 Targeting Biological Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global IL-17 Targeting Biological Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global IL-17 Targeting Biological Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market IL-17 Targeting Biological Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IL-17 Targeting Biological Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-17 Targeting Biological Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 18. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2026)
Table 19. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 20. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2027–2032)
Table 21. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 27. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 28. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021–2026)
Table 53. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2027–2032)
Table 54. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021–2026)
Table 63. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2027–2032)
Table 64. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Genrix Biopharmaceutical Company Information
Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 72. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product
Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengrui Medicine Company Information
Table 76. Jiangsu Hengrui Medicine Description and Business Overview
Table 77. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product
Table 79. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis IL-17 Targeting Biological Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. UCB IL-17 Targeting Biological Drugs Product
Table 89. UCB Recent Developments/Updates
Table 90. Eli Lilly and Co. Company Information
Table 91. Eli Lilly and Co. Description and Business Overview
Table 92. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product
Table 94. Eli Lilly and Co. Recent Developments/Updates
Table 95. Akesobio Company Information
Table 96. Akesobio Description and Business Overview
Table 97. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Akesobio IL-17 Targeting Biological Drugs Product
Table 99. Akesobio Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. DICE Therapeutics Company Information
Table 106. DICE Therapeutics Description and Business Overview
Table 107. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product
Table 109. DICE Therapeutics Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. IL-17 Targeting Biological Drugs Distributors List
Table 113. IL-17 Targeting Biological Drugs Customers List
Table 114. IL-17 Targeting Biological Drugs Market Trends
Table 115. IL-17 Targeting Biological Drugs Market Drivers
Table 116. IL-17 Targeting Biological Drugs Market Challenges
Table 117. IL-17 Targeting Biological Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of IL-17 Targeting Biological Drugs
Figure 2. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global IL-17 Targeting Biological Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global IL-17 Targeting Biological Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global IL-17 Targeting Biological Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global IL-17 Targeting Biological Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global IL-17 Targeting Biological Drugs Sales (K Units), 2021–2032
Figure 14. Global IL-17 Targeting Biological Drugs Average Price (US$/Unit), 2021–2032
Figure 15. IL-17 Targeting Biological Drugs Report Years Considered
Figure 16. IL-17 Targeting Biological Drugs Sales Share by Manufacturers in 2025
Figure 17. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global IL-17 Targeting Biological Drugs Players: Market Share by Revenue in IL-17 Targeting Biological Drugs in 2025
Figure 19. IL-17 Targeting Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 54. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 57. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. IL-17 Targeting Biological Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global IL-17 Targeting Biological Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global IL-17 Targeting Biological Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market IL-17 Targeting Biological Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IL-17 Targeting Biological Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-17 Targeting Biological Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 18. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2026)
Table 19. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 20. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2027–2032)
Table 21. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 27. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 28. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021–2026)
Table 53. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2027–2032)
Table 54. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021–2026)
Table 63. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2027–2032)
Table 64. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Genrix Biopharmaceutical Company Information
Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 72. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product
Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengrui Medicine Company Information
Table 76. Jiangsu Hengrui Medicine Description and Business Overview
Table 77. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product
Table 79. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis IL-17 Targeting Biological Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. UCB IL-17 Targeting Biological Drugs Product
Table 89. UCB Recent Developments/Updates
Table 90. Eli Lilly and Co. Company Information
Table 91. Eli Lilly and Co. Description and Business Overview
Table 92. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product
Table 94. Eli Lilly and Co. Recent Developments/Updates
Table 95. Akesobio Company Information
Table 96. Akesobio Description and Business Overview
Table 97. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Akesobio IL-17 Targeting Biological Drugs Product
Table 99. Akesobio Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. DICE Therapeutics Company Information
Table 106. DICE Therapeutics Description and Business Overview
Table 107. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product
Table 109. DICE Therapeutics Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. IL-17 Targeting Biological Drugs Distributors List
Table 113. IL-17 Targeting Biological Drugs Customers List
Table 114. IL-17 Targeting Biological Drugs Market Trends
Table 115. IL-17 Targeting Biological Drugs Market Drivers
Table 116. IL-17 Targeting Biological Drugs Market Challenges
Table 117. IL-17 Targeting Biological Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of IL-17 Targeting Biological Drugs
Figure 2. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global IL-17 Targeting Biological Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global IL-17 Targeting Biological Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global IL-17 Targeting Biological Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global IL-17 Targeting Biological Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global IL-17 Targeting Biological Drugs Sales (K Units), 2021–2032
Figure 14. Global IL-17 Targeting Biological Drugs Average Price (US$/Unit), 2021–2032
Figure 15. IL-17 Targeting Biological Drugs Report Years Considered
Figure 16. IL-17 Targeting Biological Drugs Sales Share by Manufacturers in 2025
Figure 17. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global IL-17 Targeting Biological Drugs Players: Market Share by Revenue in IL-17 Targeting Biological Drugs in 2025
Figure 19. IL-17 Targeting Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 54. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 57. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. IL-17 Targeting Biological Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232